300 related articles for article (PubMed ID: 19259415)
1. The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.
Galea AM; Murray V
Cancer Inform; 2008; 6():315-55. PubMed ID: 19259415
[TBL] [Abstract][Full Text] [Related]
2. Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression.
Kishimoto T; Yoshikawa Y; Yoshikawa K; Komeda S
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861648
[TBL] [Abstract][Full Text] [Related]
3. An Ultraviolet Resonance Raman Spectroscopic Study of Cisplatin and Transplatin Interactions with Genomic DNA.
Geng J; Aioub M; El-Sayed MA; Barry BA
J Phys Chem B; 2017 Sep; 121(38):8975-8983. PubMed ID: 28925698
[TBL] [Abstract][Full Text] [Related]
4. Transplatin enhances effect of cisplatin on both single DNA molecules and live tumor cells.
Liu YR; Ji C; Zhang HY; Dou SX; Xie P; Wang WC; Wang PY
Arch Biochem Biophys; 2013 Aug; 536(1):12-24. PubMed ID: 23664917
[TBL] [Abstract][Full Text] [Related]
5. Transplatin ineffectiveness against cancer from a molecular perspective: A single-molecule force-spectroscopy study.
Oliveira L; Caquito JM; Rocha MS
Phys Rev E; 2020 Jun; 101(6-1):062412. PubMed ID: 32688610
[TBL] [Abstract][Full Text] [Related]
6. Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.
Kasparkova J; Pospisilova S; Brabec V
J Biol Chem; 2001 May; 276(19):16064-9. PubMed ID: 11279186
[TBL] [Abstract][Full Text] [Related]
7. Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer.
Hofr C; Brabec V
J Biol Chem; 2001 Mar; 276(13):9655-61. PubMed ID: 11104778
[TBL] [Abstract][Full Text] [Related]
8. Similar pharmacokinetics and differential ototoxicity after administration with cisplatin and transplatin in guinea pigs.
Saito T; Zhang ZJ; Yamada T; Yamamoto T; Shibamori Y; Saito H
Acta Otolaryngol; 1997 Jan; 117(1):61-5. PubMed ID: 9039483
[TBL] [Abstract][Full Text] [Related]
9. Comparative thermal and thermodynamic study of DNA chemically modified with antitumor drug cisplatin and its inactive analog transplatin.
Lando DY; Chang CL; Fridman AS; Grigoryan IE; Galyuk EN; Hsueh YW; Hu CK
J Inorg Biochem; 2014 Aug; 137():85-93. PubMed ID: 24831492
[TBL] [Abstract][Full Text] [Related]
10. Relative lack of toxicity of transplatin compared with cisplatin in rodents.
Blisard KS; Harrington DA; Long DA; Jackson JE
J Comp Pathol; 1991 Nov; 105(4):367-75. PubMed ID: 1770175
[TBL] [Abstract][Full Text] [Related]
11. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
12. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells.
Burczynski ME; McMillian M; Ciervo J; Li L; Parker JB; Dunn RT; Hicken S; Farr S; Johnson MD
Toxicol Sci; 2000 Dec; 58(2):399-415. PubMed ID: 11099651
[TBL] [Abstract][Full Text] [Related]
13. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
Kasparkova J; Novakova O; Marini V; Najajreh Y; Gibson D; Perez JM; Brabec V
J Biol Chem; 2003 Nov; 278(48):47516-25. PubMed ID: 12970368
[TBL] [Abstract][Full Text] [Related]
14. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
Zaludová R; Natile G; Brabec V
Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661
[TBL] [Abstract][Full Text] [Related]
15. Nickel(II) increases the sensitivity of V79 Chinese hamster cells towards cisplatin and transplatin by interference with distinct steps of DNA repair.
Krueger I; Mullenders LH; Hartwig A
Carcinogenesis; 1999 Jul; 20(7):1177-84. PubMed ID: 10383887
[TBL] [Abstract][Full Text] [Related]
16. Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells.
Levresse V; Marek L; Blumberg D; Heasley LE
Mol Pharmacol; 2002 Sep; 62(3):689-97. PubMed ID: 12181446
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cisplatin-induced nephrotoxicity by microarray technology.
Huang Q; Dunn RT; Jayadev S; DiSorbo O; Pack FD; Farr SB; Stoll RE; Blanchard KT
Toxicol Sci; 2001 Oct; 63(2):196-207. PubMed ID: 11568363
[TBL] [Abstract][Full Text] [Related]
18. Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.
Kasparkova J; Marini V; Bursova V; Brabec V
Biophys J; 2008 Nov; 95(9):4361-71. PubMed ID: 18676645
[TBL] [Abstract][Full Text] [Related]
19. Elastic response and length change of single DNA molecules induced by a combination of cisplatin and transplatin.
Li W; Sun ZQ; Xie P; Dou SX; Wang WC; Wang PY
Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Feb; 85(2 Pt 1):021918. PubMed ID: 22463255
[TBL] [Abstract][Full Text] [Related]
20. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
Kaspárková J; Brabec V
Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
